Garen G. Bohlin, Director of Karyopharm Therapeutics KPTI, has filed 1 purchase and 2 sales on the open market. Over the past 12 months that comes to a net sale of $323.5K. The latest trade was on 05/21.

GB

GB

Garen G. Bohlin

Director

Company

Karyopharm Therapeutics KPTI

First filing

23/05/19

Trades

15 trades

Buys / sales

1 / 2

12-month net buying

−$323.5K

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Collegium PharmaceuticalCOLL	Open-market sale	05/11	05/13	8,700 sh	$37.18	$323,466	−12.3%
Collegium PharmaceuticalCOLL	Open-market sale	24/05/14	24/05/16	28,985 sh	$32.30	$936,215.5	−39.3%
Karyopharm TherapeuticsKPTI	Open-market buy	23/09/12	23/09/12	41,140 sh	$1.22	$50,190.8	+1028.5%